<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-vaccines-08-00174">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Glass</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Polhemus</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Jarman</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Friberg</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Currier</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Bonaparte</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De La Barra</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Princiotta</surname>
    <given-names>M.F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The effects of Japanese encephalitis vaccine and accelerated dosing scheduling on the immunogenicity of the chimeric yellow fever derived tetravalent dengue vaccine: A phase II, randomized, open-label, single-center trial in adults aged 18 to 45 years in the United States</article-title>
  <source>J. Infect. Dis.</source>
  <year>2019</year>
  <volume>221</volume>
  <fpage>1057</fpage>
  <lpage>1069</lpage>
 </element-citation>
</ref>
